Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer.

Saved in:
Bibliographic Details
Title: Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer.
Authors: Thöm I (AUTHOR), Andritzky B (AUTHOR), Schuch G (AUTHOR), Burkholder I (AUTHOR), Edler L (AUTHOR), Johansen JS (AUTHOR), Bokemeyer C (AUTHOR), Schumacher U (AUTHOR), Laack E (AUTHOR), Thöm, Ina1 (AUTHOR), Andritzky, Birte (AUTHOR), Schuch, Gunter (AUTHOR), Burkholder, Iris (AUTHOR), Edler, Lutz (AUTHOR), Johansen, Julia S (AUTHOR), Bokemeyer, Carsten (AUTHOR), Schumacher, Udo (AUTHOR), Laack, Eckart (AUTHOR)
Source: Cancer (0008543X). 9/1/2010, Vol. 116 Issue 17, p4114-4121. 8p.
Database: Academic Search Ultimate
Description
ISSN:0008543X
DOI:10.1002/cncr.25196